186 related articles for article (PubMed ID: 11720435)
1. A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma.
Ryan BM; McManus R; Daly JS; Carton E; Keeling PW; Reynolds JV; Kelleher D
Br J Cancer; 2001 Nov; 85(10):1499-503. PubMed ID: 11720435
[TBL] [Abstract][Full Text] [Related]
2. The p73 polymorphisms are not associated with susceptibility to esophageal squamous cell carcinoma in a high incidence region of China.
Ge H; Wang YM; Cao YY; Chen ZF; Wen DG; Guo W; Wang N; Zhang XF; Li Y; Zhang JH
Dis Esophagus; 2007; 20(4):290-6. PubMed ID: 17617876
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of p73 polymorphisms to genetic susceptibilities to esophageal carcinoma and gastric cardiac carcinoma].
Ge H; Wang YM; Cao YY; Zhang XF; Li Y; Guo W; Wang N; Zhang JH
Ai Zheng; 2006 Nov; 25(11):1351-5. PubMed ID: 17094900
[TBL] [Abstract][Full Text] [Related]
4. p73, a gene related to p53, is not mutated in esophageal carcinomas.
Nimura Y; Mihara M; Ichimiya S; Sakiyama S; Seki N; Ohira M; Nomura N; Fujimori M; Adachi W; Amano J; He M; Ping YM; Nakagawara A
Int J Cancer; 1998 Nov; 78(4):437-40. PubMed ID: 9797131
[TBL] [Abstract][Full Text] [Related]
5. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Amos CI; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Carcinogenesis; 2004 Oct; 25(10):1911-6. PubMed ID: 15180941
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the p73 gene in relation to colorectal cancer risk and survival.
Pfeifer D; Arbman G; Sun XF
Carcinogenesis; 2005 Jan; 26(1):103-7. PubMed ID: 15485994
[TBL] [Abstract][Full Text] [Related]
7. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity.
Araki D; Uzawa K; Watanabe T; Shiiba M; Miyakawa A; Yokoe H; Tanzawa H
Int J Oncol; 2002 Feb; 20(2):355-60. PubMed ID: 11788901
[TBL] [Abstract][Full Text] [Related]
8. Association between the p73 G4C14-to-A4T14 polymorphism and risk of nasopharyngeal carcinoma: a case-control and family-based study.
Zhang X; Cao P; Zhai Y; Zhang H; Cui Y; Wu Z; Yuan X; Wang Z; Li P; Yu L; Xia X; He F; Zhou G
Carcinogenesis; 2014 Sep; 35(9):1977-82. PubMed ID: 24590897
[TBL] [Abstract][Full Text] [Related]
9. Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population.
Umar M; Upadhyay R; Khurana R; Kumar S; Ghoshal UC; Mittal B
Mol Biol Rep; 2012 Feb; 39(2):1153-62. PubMed ID: 21573788
[TBL] [Abstract][Full Text] [Related]
10. Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population.
Hu Z; Miao X; Ma H; Tan W; Wang X; Lu D; Wei Q; Lin D; Shen H
Int J Cancer; 2005 Apr; 114(3):455-60. PubMed ID: 15578704
[TBL] [Abstract][Full Text] [Related]
11. Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients.
Arfaoui AT; Kriaa LB; El Hadj Oel A; Ben Hmida MA; Khiari M; Khalfallah T; Gharbi L; Mzabi S; Bouraoui S
Virchows Arch; 2010 Sep; 457(3):359-68. PubMed ID: 20644956
[TBL] [Abstract][Full Text] [Related]
12. Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target.
Imyanitov EN; Birrell GW; Filippovich I; Sorokina N; Arnold J; Mould MA; Wright K; Walsh M; Mok SC; Lavin MF; Chenevix-Trench G; Khanna KK
Oncogene; 1999 Aug; 18(32):4640-2. PubMed ID: 10467409
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
Aoki T; Miyamoto A; Marubashi S; Nagano H; Umeshita K; Fujiwara Y; Dono K; Nakamori S; Sakon M; Monden M
Int J Oncol; 2004 Feb; 24(2):441-6. PubMed ID: 14719122
[TBL] [Abstract][Full Text] [Related]
14. Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53.
Cai YC; Yang GY; Nie Y; Wang LD; Zhao X; Song YL; Seril DN; Liao J; Xing EP; Yang CS
Carcinogenesis; 2000 Apr; 21(4):683-9. PubMed ID: 10753204
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of heterozygosity at 1p36.3 and p73 abnormality in parathyroid adenomas.
Shan L; Yang Q; Nakamura Y; Nakamura M; Miyauchi A; Tsujimoto M; Nakatani Y; Wakasa K; Mori I; Kakudo K
Mod Pathol; 2001 Apr; 14(4):273-8. PubMed ID: 11301342
[TBL] [Abstract][Full Text] [Related]
16. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer.
Li G; Wang LE; Chamberlain RM; Amos CI; Spitz MR; Wei Q
Cancer Res; 2004 Oct; 64(19):6863-6. PubMed ID: 15466174
[TBL] [Abstract][Full Text] [Related]
17. Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma.
Peng CY; Tsai SL; Yeh CT; Hung SP; Chen MF; Chen TC; Chu CM; Liaw YF
Anticancer Res; 2000; 20(3A):1487-92. PubMed ID: 10928060
[TBL] [Abstract][Full Text] [Related]
18. p73 is up-regulated in a subset of hepatocellular carcinomas.
Herath NI; Kew MC; Whitehall VL; Walsh MD; Jass JR; Khanna KK; Young J; Powell LW; Leggett BA; Macdonald GA
Hepatology; 2000 Mar; 31(3):601-5. PubMed ID: 10706549
[TBL] [Abstract][Full Text] [Related]
19. Association between a p73 gene polymorphism and genetic susceptibility to non-small cell lung cancer in the South of China.
Wang SS; Guo HY; Dong LL; Zhu XQ; Ma L; Li W; Tang JX
Asian Pac J Cancer Prev; 2014; 15(23):10387-91. PubMed ID: 25556480
[TBL] [Abstract][Full Text] [Related]
20. The p73 G4C14-to-A4T14 polymorphism is associated with risk of lung cancer in the Han nationality of North China.
Zhang X; Li X; Wu Z; Lin F; Zhou H
Mol Carcinog; 2013 May; 52(5):387-91. PubMed ID: 22228141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
